{"version":"1.0","provider_name":"Actualidad CEU","provider_url":"https:\/\/medios.uchceu.es\/actualidad-ceu","author_name":"Teresa Soriano","author_url":"https:\/\/medios.uchceu.es\/actualidad-ceu\/author\/tsoriano\/","title":"The challenges of drug monitoring in oncology","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"3CY52YQ4yt\"><a href=\"https:\/\/medios.uchceu.es\/actualidad-ceu\/the-challenges-of-drug-monitoring-in-oncology\/\">The challenges of drug monitoring in oncology<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/medios.uchceu.es\/actualidad-ceu\/the-challenges-of-drug-monitoring-in-oncology\/embed\/#?secret=3CY52YQ4yt\" width=\"600\" height=\"338\" title=\"\u00abThe challenges of drug monitoring in oncology\u00bb \u2014 Actualidad CEU\" data-secret=\"3CY52YQ4yt\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/medios.uchceu.es\/actualidad-ceu\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/medios.uchceu.es\/actualidad-ceu\/wp-content\/uploads\/sites\/2\/2021\/02\/IMG_4724-scaled.jpg","thumbnail_width":2560,"thumbnail_height":1707,"description":"One of the most exciting areas in cancer research concerns patient-specific treatment with personalized drug dosages, according to Dr Vanesa Escudero, a CEU UCH researcher at the Elche campus Drug monitoring for oncology enables dosages to be adjusted and to identify the high number of patients in whom standard dosage regimens do not elicit a [&hellip;]"}